Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Amato

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 28, 2013
Anxiety state affects information processing speed in patients with multiple sclerosisBenedetta Goretti, R G Viterbo, E Portaccio, et al.
Neuroscience Letters|December 8, 2000
Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosisC Ballerini, D Campani, G Rombolà, et al.
Neurology|November 15, 2011
Cortical lesions in radiologically isolated syndromeA Giorgio, M L Stromillo, F Rossi, et al.
Neurology|February 1, 1994
Cross-national interrater agreement on the clinical diagnostic criteria for dementia. WHO-PRA Age-Associated Dementia Working Group, WHO-Program for Research on Aging, Health of Elderly ProgramM Baldereschi, M P Amato, P Nencini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2009
The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosisV Zipoli, B Hakiki, E Portaccio, et al.
European Journal of Neurology|October 13, 2012
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis--a prospective, non-randomized pilot studyE Portaccio, M L Stromillo, B Goretti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 20, 2011
Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) studyF Patti, M P Amato, M Trojano, et al.
Epidemiologia E Prevenzione|June 1, 1990
[Study Group: "Evaluation of the efficacy of therapeutic treatments in multiple sclerosis"]V Cosi, G Filippini, S Vercesi, et al.
European Journal of Neurology|August 23, 2018
Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndromeL Bonzano, M Bove, M P Sormani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 26, 2009
The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosisE Portaccio, B Goretti, S Lori, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 28, 2013
Anxiety state affects information processing speed in patients with multiple sclerosisBenedetta Goretti, R G Viterbo, E Portaccio, et al.
Neuroscience Letters|December 8, 2000
Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosisC Ballerini, D Campani, G Rombolà, et al.
Neurology|November 15, 2011
Cortical lesions in radiologically isolated syndromeA Giorgio, M L Stromillo, F Rossi, et al.
Neurology|February 1, 1994
Cross-national interrater agreement on the clinical diagnostic criteria for dementia. WHO-PRA Age-Associated Dementia Working Group, WHO-Program for Research on Aging, Health of Elderly ProgramM Baldereschi, M P Amato, P Nencini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2009
The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosisV Zipoli, B Hakiki, E Portaccio, et al.
European Journal of Neurology|October 13, 2012
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis--a prospective, non-randomized pilot studyE Portaccio, M L Stromillo, B Goretti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 20, 2011
Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) studyF Patti, M P Amato, M Trojano, et al.
Epidemiologia E Prevenzione|June 1, 1990
[Study Group: "Evaluation of the efficacy of therapeutic treatments in multiple sclerosis"]V Cosi, G Filippini, S Vercesi, et al.
European Journal of Neurology|August 23, 2018
Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndromeL Bonzano, M Bove, M P Sormani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 26, 2009
The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosisE Portaccio, B Goretti, S Lori, et al.
Pageof 11